The first report of Omakase’s new series of publications called “Omakase Lab Reports” is available for download

//The first report of Omakase’s new series of publications called “Omakase Lab Reports” is available for download

The first report of Omakase’s new series of publications called “Omakase Lab Reports” is available for download

The report titled “European Commission Approved Orphan Drugs (ODs) 2012-2016: Analysis of P&R Situation in Spain”, which is the first report of Omakase’s new publication series called “Omakase Lab Reports”, is now available for download.

In this report we identify the P&R situation in Spain of ODs approved by the European Commission between 2012-2016, and we analyse potential favourable ODs profiles for P&R approval in Spain, based on clinical, economic and institutional reimbursement variables.

Download the report here: Omakase Lab 1 2018 – P&R Orphan Drugs

2018-10-05T10:06:23+00:00March 16th, 2018|Noticias|

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the aforementioned cookies and the acceptance of our cookies policy, Click on the link for more information. ACEPTAR

Aviso de cookies